Iterum Therapeutics Plc (ITRM)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Corey N. Fishman
Employees:
10
BLOCK 2 FLOOR 3, HARCOURT CENTRE, HARCOURT STREET, DUBLIN, IRELAND 2
(872) 225-6077

Iterum Therapeutics plc is developing sulopenem, a novel anti-infective compound with oral and IV formulations. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Data derived from most recent annual or quarterly report
Market Cap 12.233 Million Shares Outstanding12.233 Million Avg 30-day Volume 86.645 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.38
Price to Revenue0.0 Debt to Equity0.528 EBITDA-76.212 Million
Price to Book Value1.2742 Operating Margin0.0 Enterprise Value9.188 Million
Current Ratio6.434 EPS Growth-0.761 Quick Ratio6.286
1 Yr BETA 1.0635 52-week High/Low 7.02 / 0.6 Profit Margin0.0
Operating Cash Flow Growth70.947 Altman Z-Score-7.0142 Free Cash Flow to Firm -48.952 Million
View SEC Filings from ITRM instead.

View recent insider trading info

Iterum Therapeutics Plc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ITRM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ITRM

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-14 by MATTHEWS JUDITH M.
  • 4: filed on 2023-03-14 by FISHMAN COREY N.
  • 4: filed on 2023-01-04 by DUNNE MICHAEL W.
  • 4: filed on 2023-01-04 by HUNT RONALD
  • 4: filed on 2022-12-05 by PUTTAGUNTA SAILAJA
  • 4: filed on 2022-09-28 by AHRENS BRENTON KARL
  • 4: filed on 2022-09-20 by AHRENS BRENTON KARL
  • 4: filed on 2022-09-15 by AHRENS BRENTON KARL
  • 4: filed on 2022-09-09 by DUNNE MICHAEL W.
  • 4: filed on 2022-06-24 by HUNT RONALD

    • Events (8k)

  • 8-K: filed on 2023-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-17:
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-15:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-19:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-19:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 8.01: Other Events
  • 8-K: filed on 2022-07-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FISHMAN COREY N. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 44,449 2023-03-11 1

    MATTHEWS JUDITH M. CHIEF FINANCIAL OFFICER

    • Officer
    		 8,135 2023-03-11 1

    HUNT RONALD

    • Director
    		 101,116 2023-01-01 6

    DUNNE MICHAEL W.

    • Director
    		 36,337 2023-01-01 8

    AHRENS BRENTON KARL

    • Director
    		 29,125 2022-12-23 7

    PUTTAGUNTA SAILAJA CHIEF MEDICAL OFFICER

    • Officer
    		 38,302 2022-12-01 1

    HECHT BETH

    • Director
    		 44,805 2022-06-23 2

    CHIN MARK

    • Director
    		 0 2022-06-23 2

    KELLY DAVID GEORGE

    • Director
    		 647,059 2022-06-15 1

    DENNER ALEXANDER J

    SARISSA CAPITAL MANAGEMENT LP

    SARISSA CAPITAL OFFSHORE MASTER FUND LP

    SARISSA CAPITAL CATAPULT FUND LLC

    SARISSA CAPITAL HAWKEYE FUND LP

    SARISSA CAPITAL MASTER FUND II LP

    • 10% Owner
    		 No longer subject to file 2021-02-11 0

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    		 No longer subject to file 2021-02-04 0

    HERON PATRICK J

    • Director
    		 1,547,322 2020-07-01 0

    SOFINNOVA VENTURE PARTNERS IX, L.P.

    SOFINNOVA MANAGEMENT IX, L.L.C.

    HEALY JAMES

    POWELL MICHAEL

    • 10% Owner
    		 No longer subject to file 2020-06-01 0

    SOFINNOVA VENTURE PARTNERS IX, L.P.

    SOFINNOVA MANAGEMENT IX, L.L.C.

    POWELL MICHAEL

    • 10% Owner
    		 0 2020-01-21 0

    HEALY JAMES

    • Director
    • 10% Owner
    		 1,732,668 2020-01-21 0

    MALIK SHAHZAD

    • Director
    		 1,259,308 2020-01-21 0

    FRAZIER HEALTHCARE VII, L.P.

    FRAZIER HEALTHCARE VII-A, L.P.

    FHM VII, L.P.

    FHM VII, L.L.C.

    • 10% Owner
    		 0 2020-01-21 0

    CANAAN X L.P.

    CANAAN PARTNERS X LLC

    • Director
    • 10% Owner
    		 0 2020-01-21 0

    EDICK PAUL R

    • Director
    		 31,390 2019-05-24 0

    SOFINNOVA VENTURE PARTNERS IX, L.P.

    POWELL MICHAEL

    SOFINNOVA MANAGEMENT IX, L.L.C.

    MEHRA ANAND

    • 10% Owner
    		 1,726,514 2018-05-30 0

    LATHI VIJAY K

    RATCLIFFE LIAM

    • 10% Owner
    		 1,456,303 2018-05-30 0

    HERON PATRICK J

    FRAZIER HEALTHCARE VII, L.P.

    FRAZIER HEALTHCARE VII-A, L.P.

    FHM VII, L.L.C.

    FHM VII, L.P.

    • Director
    • 10% Owner
    		 1,538,316 2018-05-30 0

    NEW LEAF VENTURE MANAGEMENT III, L.L.C.

    NEW LEAF VENTURE ASSOCIATES III, L.P.

    NEW LEAF VENTURES III, L.P.

    LATHI VIJAY K

    RATCLIFFE LIAM

    • 10% Owner
    		 0 2018-05-24 0

    SCHAFFNIT JEFFREY R. CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2018-05-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MATTHEWS JUDITH M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 18:00:26 -0400 2023-03-11 F 2,883 $0.96 d 8,135 direct 15.0 3.0 15.0 2 0.0 1

    MATTHEWS JUDITH M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 18:00:26 -0400 2023-03-11 A 6,666 a 11,018 direct 15.0 3.0 15.0 2 0.0 1

    MATTHEWS JUDITH M. - Officer CHIEF FINANCIAL OFFICER

    		2023-03-14 18:00:26 -0400 2023-03-11 M 6,666 d 0 direct

    FISHMAN COREY N. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-14 18:00:23 -0400 2023-03-11 F 5,683 $0.96 d 44,449 direct 15.0 3.0 15.0 2 0.0 1

    FISHMAN COREY N. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-14 18:00:23 -0400 2023-03-11 A 14,333 a 50,132 direct 15.0 3.0 15.0 2 0.0 1

    FISHMAN COREY N. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-14 18:00:23 -0400 2023-03-11 M 14,333 d 0 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 22:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 21:45:05 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 21:15:03 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 20:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 20:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 19:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 19:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 18:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 18:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 17:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 17:15:03 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 16:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 16:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 15:45:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 15:15:03 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 14:45:04 UTC -0.5954 5.4154 200000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 14:15:04 UTC -0.5954 5.4154 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 13:45:03 UTC -0.667 5.487 250000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 13:15:03 UTC -0.667 5.487 200000
    ITERUM THERAPEUTICS PLC ITRM 2023-03-31 12:45:03 UTC -0.667 5.487 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments